CRISPR patent battle in Europe takes a ‘wild’ twist with surprising player – Science Magazine
Science Magazine |
CRISPR patent battle in Europe takes a 'wild' twist with surprising player
Science Magazine The European Patent Office (EPO) on 27 July signaled that it intends to grant a patent to MilliporeSigma, which operates in the United States and Canada, for the use of CRISPR to splice genetic information into eukaryotic cells. Just such a “knock-in … |
